Kavar Capital Partners Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7	Closed	–	–	321
2015 Q4	$0	Buy	7 +1	+17%	–	﹤0.01%	515
2015 Q3	$0	Buy	6 +1	+20%	–	﹤0.01%	524
2015 Q2	$0	Buy	+5	New	–	﹤0.01%	532